Detalles de la búsqueda
1.
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection.
Hematol Oncol
; 41(5): 904-911, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37452579
2.
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study.
Infection
; 50(5): 1243-1253, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35488112
3.
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis.
Mycoses
; 64(11): 1317-1327, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34387004
4.
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study).
Int J Antimicrob Agents
; 61(3): 106734, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36690123
5.
Patients with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for hepatitis C virus.
AIDS
; 35(12): 1967-1972, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34101631
6.
Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections.
Open Forum Infect Dis
; 6(12): ofz505, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31858018
7.
Risk factors for treatment failure in patients receiving ß-lactam/ß-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study.
Int J Antimicrob Agents
; 53(5): 574-581, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30639527
Resultados
1 -
7
de 7
1
Próxima >
>>